Embed Size (px)
Citation preview
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
DAILY EQUITY REPORT
Our Presence
Epic Research India
411 Milinda Manor (Suites 409- 417)
2 RNT Marg. Opp Central Mall
Indore (M.P.)
Hotline: +91 731 664 2300
Or give us a missed call at
026 5309 0639
HNI & NRI Sales Contact Australia
Mintara Road, Tarneit, Victoria. Post Code 3029
Phone.: +61 422 063855
HNI & NRI Sales Contact USA
2117 Arbor Vista Dr. Charlotte (NC)
Cell: +1 704 249 2315
Toll Free Number
1-800-200-9454
All queries should be directed to
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
DAILY MARKET WRAPUP
INDIAN INDICES
INDEX CMP Change % Chg
NIFTY 8349.35 -85.75 -1.02
SENSEX 27034.50 -274.10 -1.00
SECTORAL INDICES
Index Current % Change Open High Low Prev. Close
CNX AUTO 9,601.00 -1.11 9,684.30 9,716.15 9,590.50 9,709.00
CNX ENERGY 10,407.10 -1.25 10,539.90 10,553.30 10,391.25 10,538.65
CNX FINANCE 7,505.50 -1.59 7,574.55 7,591.15 7,494.55 7,626.70
CNX FMCG 21,641.05 0.03 21,623.90 21,723.35 21,596.60 21,634.15
CNX INFRA 2,841.10 -1.78 2,888.85 2,893.35 2,838.05 2,892.70
CNX IT 10,132.65 -0.88 10,165.50 10,192.70 10,113.20 10,222.15
CNX MEDIA 2,705.05 -1.82 2,754.30 2,762.40 2,697.10 2,755.25
CNX METAL 2,933.10 -2.42 2,996.45 3,009.30 2,922.05 3,005.80
CNX MNC 10,163.95 -0.87 10,231.65 10,266.40 10,136.05 10,253.15
NI15 5,241.15 -0.36 5,247.15 5,262.70 5,231.60 5,260.00
CNX PHARMA 10,307.85 -0.79 10,385.75 10,434.05 10,281.80 10,389.75
CNX PSE 3,903.20 -1.53 3,962.55 3,965.75 3,892.40 3,963.80
CNX PSU BANK 3,040.10 -3.08 3,133.00 3,158.15 3,032.45 3,136.75
CNX REALTY 177.35 -2.23 180.75 182.55 176.90 181.40
CNX SERVICE 10,543.20 -1.19 10,613.50 10,641.05 10,530.10 10,670.20
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
EPIC RESEARCH– ANALYST SPEAKS
NIFTY on Friday saw a huge selling pressure due to Trump’s presidential ceremony ahead. The index closed down losing as much as 80 points. It took a perfect turn from 50% level on hourly chart it has given breakout of double bottom. But soon near 8280-8250 it also has support of 200 EMA and Fibonacci’s 38.5% on daily charts. So we advise you to sell it from around 8360-8350 for the targets of 8300 and 8250 with stop loss of 8435.
NIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
8453.90 8401.60 8371.20 8318.90 8288.50
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
EPIC RESEARCH– ANALYST SPEAKS
Banknifty on last trading day faced mixed impact of Friday and U.S. presidential ceremony and fell down 280 points. Though the index has support of 100 EMA around 18700 but RSI suggests overall weakness. So we advise you to sell banknifty from around 18880-18850 for the targets of 18750 and 18600 with strict stop loss of 19050
BANKNIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
19172.00 18996.00 18894.0 18718.00 18616.00
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
EPIC RESEARCH– ANALYST SPEAKS
Last trading session TATAMOTORS future maintain 520 support level but not break this level close near this level with bearish
candlestick in daily chart. And since last session it rose with rising OI in short ,So if stock break previous day low we may see sharp
downfall ahead, For that it will good to sell below 521 for the target of 516-510 with SL of 527.
TATAMOTORS FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
EPIC RESEARCH– ANALYST SPEAKS
CANBK Future show under pressure during the Day and ended near day’s low with bearish candlestick in daily chart, And since last
session it rose with rising OI in short side, So if stock break previous day low we may see sharp downfall ahead . It will good to sell
below 268 for the target of 265-260 with SL of 277.
CANBK FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
23rd JANUARY 2017
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up
on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of
the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer
to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then
Serious Legal Actions can be taken.
DISCLAIMER
